Rangwala Reshma (CIK 1825322) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-15). Recent activity: Buy KPTI (947 shares), Sell KPTI (408 shares), Sell KPTI (449 shares), Sell KPTI (5,066 shares), Buy KPTI (32,415 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-15 | Karyopharm Therapeutics Inc. (KPTI) | EVP & Chief Medical Officer | Buy | 947 | $0 |
| 2026-05-15 | Karyopharm Therapeutics Inc. (KPTI) | EVP & Chief Medical Officer | Sell | 408 | $3,876 |
| 2026-04-22 | Karyopharm Therapeutics Inc. (KPTI) | EVP & Chief Medical Officer | Sell | 449 | $4,014 |
| 2026-03-03 | Karyopharm Therapeutics Inc. (KPTI) | EVP & Chief Medical Officer | Sell | 5,066 | $47,671 |
| 2026-02-03 | Karyopharm Therapeutics Inc. (KPTI) | EVP & Chief Medical Officer | Buy | 32,415 | $0 |
| 2025-09-16 | Karyopharm Therapeutics Inc. (KPTI) | EVP & Chief Medical Officer | Buy | 945 | $0 |
| 2025-09-16 | Karyopharm Therapeutics Inc. (KPTI) | EVP & Chief Medical Officer | Sell | 408 | $2,623 |
| 2025-04-24 | Karyopharm Therapeutics Inc. (KPTI) | EVP & Chief Medical Officer | Sell | 419 | $2,585 |
| 2025-03-06 | Karyopharm Therapeutics Inc. (KPTI) | EVP & Chief Medical Officer | Sell | 3,587 | $22,562 |
| 2025-03-04 | Karyopharm Therapeutics Inc. (KPTI) | EVP & Chief Medical Officer | Buy | 5,416 | $0 |
| 2025-03-04 | Karyopharm Therapeutics Inc. (KPTI) | EVP & Chief Medical Officer | Buy | 4,583 | $0 |
Source: SEC Form 4 filings · as of 2026-05-15